Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC clinical research network
AIR-NET试验的设计和原理：一项随机、开放标签、多因素、多中心、适应性平台试验，旨在利用一系列重新利用的抗炎疗法改善EMBARC临床研究网络中支气管扩张患者的预后。
期刊:Erj Open Research
影响因子:4
doi:10.1183/23120541.00719-2025
Long, Merete B; New, Jaa Ming; Stobo, Jamie; Band, Margaret; McLaren-Neil, Fiona; Hull, Rebecca; Gilmour, Amy; Lind, Holly; McIntosh, Eve; Galloway, Rachel; Eke, Zsofia; Harris, Bridget; Singanayagam, Aran; Shah, Anand; Huang, Jeffrey; Wilkinson, Tom; Loebinger, Michael R; Haworth, Charles S; Chotirmall, Sanjay H; De Soyza, Anthony; Chalmers, James D
